{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T02:51:44Z","timestamp":1781232704162,"version":"3.54.1"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,10,5]],"date-time":"2017-10-05T00:00:00Z","timestamp":1507161600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,10,5]],"date-time":"2017-10-05T00:00:00Z","timestamp":1507161600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["p30"],"award-info":[{"award-number":["p30"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1007\/s00520-017-3879-1","type":"journal-article","created":{"date-parts":[[2017,10,5]],"date-time":"2017-10-05T01:52:15Z","timestamp":1507168335000},"page":"731-737","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Relationship between phase I study duration and symptom burden"],"prefix":"10.1007","volume":"26","author":[{"given":"Michelle","family":"Treasure","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Daly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pingfu","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetoslava","family":"Kerpedjieva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afshin","family":"Dowlati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neal J.","family":"Meropol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,10,5]]},"reference":[{"issue":"2","key":"3879_CR1","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1200\/JCO.2000.18.2.421","volume":"18","author":"JD Cheng","year":"2000","unstructured":"Cheng JD, Hitt J, Koczwara B, Schulman KA et al (2000) Impact of quality of life on patient expectations regarding phase I clinical trials. J Clin Oncol 18(2):421\u2013428 \n                    http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10637258","journal-title":"J Clin Oncol"},{"key":"3879_CR2","doi-asserted-by":"publisher","unstructured":"Manne S, Kashy D, Albrecht T et al (2014) Attitudinal barriers to participation in oncology clinical trials: factor analysis and correlates of barriers. Eur J Cancer Care (Engl). \n                    https:\/\/doi.org\/10.1111\/ecc.12180","DOI":"10.1111\/ecc.12180"},{"issue":"11","key":"3879_CR3","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/S1470-2045(06)70910-X","volume":"7","author":"E Basch","year":"2006","unstructured":"Basch E, Iasonos A, McDonough T et al (2006) Patient versus clinician symptom reporting using the National Cancer Institute Common Terminology Criteria for Adverse Events: results of a questionnaire-based study. Lancet Oncol 7(11):903\u2013909. \n                    https:\/\/doi.org\/10.1016\/S1470-2045(06)70910-X","journal-title":"Lancet Oncol"},{"issue":"11","key":"3879_CR4","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1016\/S0895-4356(02)00479-1","volume":"55","author":"KCA Sneeuw","year":"2002","unstructured":"Sneeuw KCA, Sprangers MAG, Aaronson NK (2002) The role of health care providers and significant others in evaluating the quality of life of patients with chronic disease. J Clin Epidemiol 55(11):1130\u20131143 \n                    http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12507678\n                    \n                  . Accessed August 14, 2016","journal-title":"J Clin Epidemiol"},{"issue":"2","key":"3879_CR5","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1002\/cncr.24025","volume":"115","author":"E Finlay","year":"2009","unstructured":"Finlay E, Lu HL, Henderson H, O\u2019Dwyer PJ, Casarett DJ (2009) Do phase 1 patients have greater needs for palliative care compared with other cancer patients? Cancer 115(2):446\u2013453. \n                    https:\/\/doi.org\/10.1002\/cncr.24025","journal-title":"Cancer"},{"issue":"7","key":"3879_CR6","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1177\/1049909111400723","volume":"28","author":"JM Healy","year":"2011","unstructured":"Healy JM, Patel T, Lee S, Sanchez-Reilly S (2011) Do symptoms matter when considering patients for phase I clinical trials?: a pilot study of older adults with advanced cancer. Am J Hosp Palliat Care 28(7):463\u2013466. \n                    https:\/\/doi.org\/10.1177\/1049909111400723","journal-title":"Am J Hosp Palliat Care"},{"issue":"6","key":"3879_CR7","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1200\/JCO.2013.49.8808","volume":"32","author":"DM Hyman","year":"2014","unstructured":"Hyman DM, Eaton AA, Gounder MM et al (2014) Nomogram to predict cycle-one serious drug-related toxicity in phase I oncology trials. J Clin Oncol 32(6):519\u2013526. \n                    https:\/\/doi.org\/10.1200\/JCO.2013.49.8808","journal-title":"J Clin Oncol"},{"issue":"6","key":"3879_CR8","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1016\/j.jpainsymman.2014.02.005","volume":"48","author":"KA Martinez","year":"2014","unstructured":"Martinez KA, Snyder CF, Malin JL, Dy SM (2014) Is race\/ethnicity related to the presence or severity of pain in colorectal and lung cancer? J Pain Symptom Manag 48(6):1050\u20131059. \n                    https:\/\/doi.org\/10.1016\/j.jpainsymman.2014.02.005","journal-title":"J Pain Symptom Manag"},{"issue":"18","key":"3879_CR9","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1001\/archinternmed.2010.337","volume":"170","author":"K Kroenke","year":"2010","unstructured":"Kroenke K, Zhong X, Theobald D, Wu J, Tu W, Carpenter JS (2010) Somatic symptoms in patients with cancer experiencing pain or depression: prevalence, disability, and health care use. Arch Intern Med 170(18):1686\u20131694. \n                    https:\/\/doi.org\/10.1001\/archinternmed.2010.337","journal-title":"Arch Intern Med"},{"issue":"6","key":"3879_CR10","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1200\/JCO.2015.63.0830","volume":"34","author":"E Basch","year":"2016","unstructured":"Basch E, Deal AM, Kris MG et al (2016) Symptom monitoring with patient-reported outcomes during routine cancer treatment: a randomized controlled trial. J Clin Oncol 34(6):557\u2013565. \n                    https:\/\/doi.org\/10.1200\/JCO.2015.63.0830","journal-title":"J Clin Oncol"},{"issue":"32","key":"3879_CR11","doi-asserted-by":"publisher","first-page":"5133","DOI":"10.1200\/JCO.2007.12.4644","volume":"25","author":"J Lipscomb","year":"2007","unstructured":"Lipscomb J, Reeve BB, Clauser SB et al (2007) Patient-reported outcomes assessment in cancer trials: taking stock, moving forward. J Clin Oncol 25(32):5133\u20135140. \n                    https:\/\/doi.org\/10.1200\/JCO.2007.12.4644","journal-title":"J Clin Oncol"},{"issue":"8","key":"3879_CR12","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1200\/JCO.2007.13.3439","volume":"26","author":"CC Gotay","year":"2008","unstructured":"Gotay CC, Kawamoto CT, Bottomley A, Efficace F (2008) The prognostic significance of patient-reported outcomes in cancer clinical trials. J Clin Oncol 26(8):1355\u20131363. \n                    https:\/\/doi.org\/10.1200\/JCO.2007.13.3439","journal-title":"J Clin Oncol"},{"issue":"34","key":"3879_CR13","doi-asserted-by":"publisher","first-page":"5816","DOI":"10.1200\/JCO.2009.23.7420","volume":"27","author":"B Movsas","year":"2009","unstructured":"Movsas B, Moughan J, Sarna L et al (2009) Quality of life supersedes the classic prognosticators for long-term survival in locally advanced non-small-cell lung cancer: an analysis of RTOG 9801. J Clin Oncol 27(34):5816\u20135822. \n                    https:\/\/doi.org\/10.1200\/JCO.2009.23.7420","journal-title":"J Clin Oncol"},{"issue":"32","key":"3879_CR14","doi-asserted-by":"publisher","first-page":"5051","DOI":"10.1200\/JCO.2007.11.3324","volume":"25","author":"DW Bruner","year":"2007","unstructured":"Bruner DW, Bryan CJ, Aaronson N et al (2007) Issues and challenges with integrating patient-reported outcomes in clinical trials supported by the National Cancer Institute-sponsored clinical trials networks. J Clin Oncol 25(32):5051\u20135057. \n                    https:\/\/doi.org\/10.1200\/JCO.2007.11.3324","journal-title":"J Clin Oncol"},{"issue":"9","key":"3879_CR15","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1056\/NEJMsa042220","volume":"352","author":"E Horstmann","year":"2005","unstructured":"Horstmann E, McCabe MS, Grochow L et al (2005) Risks and benefits of phase 1 oncology trials, 1991 through 2002. N Engl J Med 352(9):895\u2013904. \n                    https:\/\/doi.org\/10.1056\/NEJMsa042220","journal-title":"N Engl J Med"},{"key":"3879_CR16","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/jncimonographs\/lgm005","volume":"37","author":"CS Cleeland","year":"2007","unstructured":"Cleeland CS (2007) Symptom burden: multiple symptoms and their impact as patient-reported outcomes. J Natl Cancer Inst Monogr 37:16\u201321. \n                    https:\/\/doi.org\/10.1093\/jncimonographs\/lgm005","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"7","key":"3879_CR17","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/S0895-4356(98)00040-7","volume":"51","author":"KC Sneeuw","year":"1998","unstructured":"Sneeuw KC, Aaronson NK, Sprangers MA, Detmar SB, Wever LD, Schornagel JH (1998) Comparison of patient and proxy EORTC QLQ-C30 ratings in assessing the quality of life of cancer patients. J Clin Epidemiol 51(7):617\u2013631 \n                    http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9674669\n                    \n                  . Accessed August 14, 2016","journal-title":"J Clin Epidemiol"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00520-017-3879-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-017-3879-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-017-3879-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T15:10:25Z","timestamp":1589641825000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00520-017-3879-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,5]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["3879"],"URL":"https:\/\/doi.org\/10.1007\/s00520-017-3879-1","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,5]]},"assertion":[{"value":"19 March 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}